Rapid & sustained benefit of benralizumab in severe eosinophilic asthma: the BE-REAL study
{{output}}
Background: Benralizumab is an anti-IL-5Rα antibody used as add-on maintenance therapy in patients with severe eosinophilic asthma (SEA). Materials and methods: ... ...
